<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR2">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <collab>American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus Newborn</collab>
  </person-group>
  <article-title>Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections</article-title>
  <source>Pediatrics</source>
  <year>2003</year>
  <volume>112</volume>
  <fpage>1442</fpage>
  <lpage>1446</lpage>
  <pub-id pub-id-type="pmid">14654627</pub-id>
 </element-citation>
</ref>
